Domestic makers struggling to cope with sluggish OTC sales via price increase

Published: 2008-03-25 07:00:00

Updated: 2008-03-25 07:00:00

Local pharmaceutical manufacturers are poised to increase the prices of their flagship products in a bid to achieve their sales target this year, as rising global prices of crops, oil and other raw materials are weighing on the Korean economy, for which the 6 percent growth target seems difficult...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK